Anti-Asthma TDM Assay Kits Market

Analysis by Product Type (ELISA Assay Kits, Immunoassay Kits, and Others); by Assay Type (Anti-Asthma, and Bronchodilator); and by End-User (Hospitals, Diagnostic Laboratories, and Research Centers & Academic Institutes) – Global Supply & Demand Analysis & Opportunity Outlook 2023-2035

Buy Now
Report ID: 4143 | Published On: Feb 20, 2023
Request Free Sample Copy

Global Anti-Asthma TDM Assay Kits Market Size, Forecast, and Trend Highlights Over 2023 - 2035

The global anti-asthma TDM assay kits market is estimated to garner a revenue of USD 32 Billion by the end of 2035 by growing at a CAGR of ~6% over the forecast period, i.e., 2023 – 2035. Further, the market generated a revenue of USD 18 Billion in the year 2022. The growth of the market can be attributed to the escalating cases of asthma worldwide. TDM is used to measure the plasma concentration of the drug in the given therapy, and it involves measuring drug concentration and clinical interpretation of the result. Asthma is thought to affect at least 300 million individuals worldwide, 30 million of whom reside in mainland China.


In addition to these, factors that are believed to fuel the market growth of anti-asthma TDM assay kits include the rise in the consumption of tobacco. Scientists claim that tobacco smoke is a common trigger for asthma. The smoke from tobacco products, such as cigars, cigarettes, or pipes can aggravate the condition. The data released by the World Health Organization states that in 2020, 22.3% of the world population used tobacco. On account of excessively increasing tobacco users, the global anti-asthma TDM assay kits market is estimated to grow during the forecast period. Also, the worsening air quality is causing various respiratory diseases and asthma is the most common of all. This is also estimated to fuel the global anti-asthma TDM assay kits market growth during the forecast period. The World Health Organization (WHO) estimates that, as of 2019, 99% of the world's population resided in areas where the WHO's air quality standards were not being met. According to data from the same year, more than 90% of individuals worldwide lived in regions where PM2.5 concentrations were higher than the WHO annual air quality criteria (AQG), which are 10 g/m3.

Get more information on this report: Request Sample PDF

Global Anti-Asthma TDM Assay Kits Market: Key Insights

Base Year


Forecast Year




Base Year Market Size (2022)

~ USD 18 Billion

Forecast Year Market Size (2035)

~ USD 32 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Global Anti-Asthma TDM Assay Kits Market: Growth Drivers and Challenges

Growth Drivers

  • Increasing Consumption of Tobacco – Smoke affects the airways, which results in the same symptoms that occur during an asthma attack: swelling, narrowing, and the buildup of sticky mucus. Moreover, even if a person does not smoke, asthma can occur owing to secondhand smoke or passive smoking. Moreover, the pollutants from tobacco in the air can lead to acute sinusitis, which requires acute sinusitis treatment at an earlier stage, and it is anticipated to boost the market’s growth. According to the World Health Organization, around 1.2 million of those fatalities are caused by non-smokers being exposed to secondhand smoke, while more than 7 million are caused by direct tobacco use. Moreover, each year, more than 8 million people are killed by tobacco.
  • Rising Cases of Asthma – Growing cases of asthma are expected to boost the demand for anti-asthma TDM assay kits. In the US, 25 million people suffer from asthma. This equates to about 1 in every 13 people. Over 20 million Americans age 18 and over suffer from asthma.

  • Increasing Concentration of Pollutants in the Air– As per the data of the Environmental Protection Agency, between the years 1990-2020, the level of concentration of carbon monoxide and nitrogen increased by 73% and 61%, respectively. Moreover, the emission of sulfur dioxide increased by 91%, and the concentration of ozone and coarse particulate matter leveled up by 25% and 26%, respectively.

  • Growing Demand for Medical Precaution for Asthma – Diagnostic test can help the patient to know the severity of the issue and asthma & COPD drugs can help to even prevent it. Over the previous four years, sales of anti-asthma medications have increased by over 50% throughout the nation.

  • Rising Investment in Medicines for Asthma– The British pharmaceutical, AstraZeneca is investing about USD 77 million to increase respiratory drug production at its Sydney facility. This facility is expected to fulfill the rising demand in China for anti-asthmatic drugs.


  • Shortage of skilled workers who can perform the test efficiently- The increasing cases of asthma in the world is growing the demand for anti-asthma TDM assay kits. These tests are best performed by the skilled worker, to acquire a result with precision. Therefore, a dearth of skilled workers is expected to hamper the market growth.
  • Lack of medical reimbursement policies for asthma patient
  • Lack of Awareness about anti-asthma test kits

Market Segmentation

The global anti-asthma TDM assay kits market is segmented and analyzed for demand and supply by product type into ELISA assay kits, immunoassay kits, and others. Out of the three types of products, the ELISA assay kits segment is estimated to gain the largest market share over the projected time frame. The enzyme-linked immunosorbent assay, or ELISA test, quantifies the quantity of allergen-specific antibodies in our body. The growth of the segment can be attributed to the rise in the number of variants of ELISA test kits manufactured in the market. For instance, a leading manufacturer of China, Wuhan Fine Biotech Co., Ltd. currently have more than 7600 types of ELISA kits in the market.

The global anti-asthma TDM assay kits market is also segmented and analyzed for demand and supply by end-user in hospitals, diagnostic laboratories, research centers & academic institutes. Amongst these three segments, the hospital segment is expected to garner a significant share. Patients suffering from asthma often visit hospitals for treatment, and Acute asthma attacks continue to be a common reason for ER visits and hospital admissions. In 2018, around 6 million asthma patients visited hospitals for treatment. Moreover, in the same year, around 180,000 people were discharged from hospital inpatient care and nearly 2 million asthmatic patients were released from the hospital's emergency department. Furthermore, asthma-related visits to the emergency room are approximately five times as common among black Americans than among white Americans.

Our in-depth analysis of the global anti-asthma TDM assay kits market includes the following segments:

         By Product Type

  • ELISA Assay Kits
  • Immunoassay Kits
  • Others

            By Assay Type

  • Anti-Asthma
  • Bronchodilator

            By End User

  • Hospitals
  • Diagnostic Laboratories
  • Research Centers & Academic Institutes

Global Anti-Asthma TDM Assay Kits Market Regional Synopsis

The North American anti-asthma TDM assay kits market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2035. The growth of the market can be attributed majorly to the increasing count of patients suffering from asthma. A recent report published by the Asthma and Allergy Foundation of America states that approximately 25 million people living in the United States have asthma. On the other hand, the deteriorating quality of air in the region is expected to boost the market growth in the region. Research by the American Lung Association found that more than 135 million Americans breathe toxic air, putting their health and lives in danger.


Get more information on this report: Request Sample PDF

Top Featured Companies Dominating the Global Anti-Asthma TDM Assay Kits Market

    • F. Hoffmann-La Roche Ltd.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Bio-Techne Corporation
    • Svar Life Science AB
    • Thermo Fisher Scientific Inc.
    • Eagle Biosciences, Inc.
    • Merck KGaA
    • Elabscience Biotechnology Inc.
    • MyBioSource Inc.
    • Creative Diagnostics
    • Diagnostic Automation (Cortez Diagnostics, Inc.)


In The News

  • April 2022: IBSRELA the first and only NHE3 inhibitor for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults, has been made available by the biopharmaceutical company Ardelyx. The first Ardelyx product to receive approval from the US Food and Drug Administration is IBSRELA.
  • March 2022: Indegene a provider of technology-driven healthcare solutions, & meta Me Health, a maker of Regulora and a Prescription Digital Therapeutics (PDT) business, teamed up to offer Regulora as a remedy for irritable bowel syndrome-related stomach pain (IBS).

Global Economic Impact

Request Insights
Despite Inflation & Fearing Recession, Businesses Across the Globe Expected to Do Better in 2023:

In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.

Key Questions Answered in the Report

1) What are the major factors driving the growth of the anti-asthma TDM assay kits market?

Ans: The rising cases of asthma, rising air pollution, and growing demand for anti-asthma drugs are expected to be the major factor driving the growth of the global anti-asthma TDM assay kits market during the forecast period.

2) What would be the CAGR of anti-asthma TDM assay kits market over the forecast period?

Ans: The market is anticipated to attain a CAGR of ~6% over the forecast period, i.e., 2023 – 2035.

3) What are the challenges affecting the anti-asthma TDM assay kits market growth?

Ans: Lack of awareness regarding anti-asthma TDM assay kits, and there are very less skilled workers present to perform this test are estimated to be the growth hindering factors for the market expansion.

4) Which region will provide more business opportunities for growth of anti-asthma TDM assay kits market in future?

Ans: The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

5) Who are the major players dominating the anti-asthma TDM assay kits market?

Ans: The major players in the market are Bio-Techne Corporation, Svar Life Science AB, Thermo Fisher Scientific Inc., Eagle Biosciences, Inc., Merck KGaA, Elabscience Biotechnology Inc., MyBioSource Inc., Creative Diagnostics, Diagnostic Automation (Cortez Diagnostics, Inc.), and F. Hoffmann-La Roche Ltd.

6) How are the company profiles selected?

Ans: The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

7) What are the segments in the anti-asthma TDM assay kits market?

Ans: The market is segmented by product type, assay type, end user, and by region.

8) Which sub-segment captures the largest market size in the end-user segment in the anti-asthma TDM assay kits market?

Ans: The ELISA assay kits segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

Let Us Hear About Your Requirements:

Submit Your Request For Proposal (RFP)

Request Research Report Sample